BL-B01D1 + SI-B003

· Sichuan Baili Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BL-B01D1 + SI-B003, covering 2025-09-26 to 2025-09-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Extensive Stage Small Cell Lung Cancer [Phase 2]

See pricing